No Data
No Data
With a 52% Stake, Pro Medicus Limited (ASX:PME) Insiders Have a Lot Riding on the Company
This ASX 200 Med-tech Stock Has No Debt, Pays Dividends and Is Growing at 30% per Year!
The Pro Medicus Ltd (ASX: PME) share price has performed exceptionally for shareholders over the last year, rising 99%.
Best 3 ASX 200 Healthcare Shares for Price Growth in FY24
In this article, we examine the best ASX 200 healthcare shares of FY24 based on share price growth.
AU Evening Wrap: Australia Shares Rise 1.2%, Boosted by Large-Cap Companies
Australia shares rise 1.2%, boosted by large-cap companies.
Pro Medicus Target Price Raised 19% to A$95.00/Share by Citi>PME.AU
Pro Medicus Target Price Raised 19% to A$95.00/Share by Citi>PME.AU
How ASX Shares Vs. Property Performed in June
That was the 17th consecutive month of growth for the national median price.
No Data